Sign in
TerminatedNo phase

Wearable Bioimpedance Analyzer for Tracking Body Composition Changes

Key facts

Who runs it
University of Iowa
Where
Iowa City, United StatesSee the site
Trial code
Status
Terminated
People taking part
60 people enrolled
Started
14 Jul 2023
Ended
8 Oct 2024
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • InBody Band 2
Record updated
30 June 2026
Why it stopped
Lack of feasibility due to study device issues.

Who can take part

Age
18 years to 99 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Adults >/= 18 years
  • BMI > 40kg/m2
  • Presenting to bariatric arthroplasty clinic with desire for total joint arthroplasty procedure
  • Owns a smartphone capable of handling iOS or Google Play apps
  • Has a wrist circumference less than or equal to 7.7"

Who cannot take part

  • Has a pacemaker or other electronic pacemaker placement
  • Inability to complete study protocols
  • Inability to stand unsupported for 60-90 seconds
  • Does not own a smart phone capable of handling iOS or Google Play apps
  • Has a wrist circumference greater than 7.7"

Where in United States

  • University of Iowa Hospitals & ClinicsIowa City, United States

About the trial

What the trial wants to find out

Obesity, namely at body mass index (BMI) levels exceeding 40kg/m2 (class III obesity), is a risk factor for many diseases including osteoarthritis (OA). In arthroplasty, patients in this population frequently present for and are turned away from surgical intervention. Subsequently, efforts are made to decrease BMI through simple weight loss, yet these have been suggested as ineffective and counterproductive. Furthermore, simple weight loss may include muscle mass loss, which is an additional risk factor for surgery. At the University of Iowa Hospitals and Clinics Orthopedics Department, efforts have been made to encourage muscle mass gain and body fat loss over simple weight loss where progress has been tracked through stationary, multi-frequency bioimpedance analysis (BIA). BIA is a readily available technology offered to industry and consumers, and BIA has recently been incorporated into wearable devices. In the UIHC Orthopedics department, a novel clinic aimed at holistically serving the osteoarthritic-class III obese population for controlled and monitored weight loss through BIA.

Read full original descriptionShow less

This study, a randomized controlled trial, aims to recruit adult patients with class III obesity presenting to the arthroplasty-obesity clinic. While all patients will receive individual body composition coaching to increase muscle mass and decrease body fat mass, they will be randomized to one of two cohorts: the study group will receive a wearable BIA wristband (InBody BAND 2) and instruction on its use in addition to the standard coaching, and the control group will only receive the standard coaching.

This study aims to identify if the use of a wearable BIA wristband aids in the desired body composition changes. In addition, this study aims to quantify the body composition changes exhibited by each cohort. Finally, this study aims to track surgical outcomes for those patients that are indicated for total joint arthroplasty.

The 2 groups in the trial

  • Wearable Device GroupTreatment being tested

    Will be given InBody Band 2 to use while trying to achieve weight loss goal prior to total joint arthroplasty.

    Treatment: InBody Band 2

  • Control GroupNo study treatment, for comparison

    Will not be given InBody Band 2 to use while trying to achieve weight loss goal prior to total joint arthroplasty.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
30 June 2026